Specific Diagnostics has developed in vitro diagnostic systems based upon a unique, patented metabolomic signature technology that enables rapid detection and identification of microorganisms as they grow in culture. Its first commercial application applies this fundamental new capability to the rapid determination of antimicrobial susceptibility directly from positive blood cultures, as well as isolate dilutions.
Specific is based in San Jose, CA.
Specific Diagnostics has been acquired by bioMérieux, a global company specializing in in vitro diagnostics and infectious diseases.
For more latest information about SPECIFIC REVEALTM, please visit the bioMérieux website.
Utilizing our unique, patented technology, our mission is to enable action. By providing rapid, accurate, and actionable results, clinicians can treat sooner allowing patients to recover faster with less antibiotic usage.
To lead the global diagnostics industry in creating a world where clinicians receive instant, actionable information and patients no longer wait hours and days on diagnostic results before receiving their diagnosis and treatment.
The PATIENT is at the forefront of everything we do.
INNOVATION starts with all of us.
Our work is creating an EVOLUTION in healthcare.